When you’re under pressure to bring new therapies to market faster, you can’t let data silos slow you down. You need a centralized life sciences content management system for seamless data access, collaboration, and compliance that lets you focus on what matters — sound research and development (R&D) that saves lives.
In this blog, we look at the top challenges of biotech and pharmaceutical content management and how to leverage the cloud in life sciences to break down silos and accelerate scientific innovation.
What is life sciences content management?
Life sciences content management is the systematic organization, storage, retrieval, and secure handling of information related to biological research, healthcare, and pharmaceuticals. It’s important for data accessibility, compliance, and collaboration, which impact research, patient care, and regulatory requirements. Here’s why.
Researchers collect more data than ever
Scientific advancements such as high-throughput screening (HTS) have added even more complexity to drug discovery workflows. A massive amount of data is generated in tests to identify specific molecules, proteins, genes, or biological pathways associated with a particular disease or condition. Also, as part of R&D workflows, drug candidates undergo extensive testing to guarantee their efficiency and safety, resulting in even more data for scientists to store, process, and analyze.
Life sciences research increasingly relies on collaboration
Knowledge sharing helps bring drugs to market faster. However, if you have disparate repositories, cross-functional teams lose time trying to find the data they need.
And the challenges don’t stop there, as a lack of standardized formats leads to inconsistency and difficulties in aggregating information. In fact, about two-thirds of respondents of the 2022 State of Digital Lab Transformation study said they had trouble accessing data – with scientists having to wait from one hour to more than one day to get hold of the data they needed for analysis. This inefficiency lowers productivity, hinders collaboration, and lengthens R&D timelines.
The life sciences industry operates within a framework of extensive and stringent regulations to ensure the safety and efficacy of products and treatments developed in this field. No wonder PhRMA statistics indicate that only 12% of new molecular entities that enter clinical trials eventually receive approval from the US Food and Drug Administration (FDA).
The complexity and the scope of regulations pose compliance challenges, calling for increased security measures and comprehensive audit checks. The data generated during research, clinical trials, and manufacturing processes must be protected to maintain the integrity and confidentiality of sensitive information while also allowing authorized personnel to access it efficiently.
The life sciences industry experiences one of the highest data breach costs
Pharmaceutical and biotech companies are a prime target for cyberattacks due to the significant value of their intellectual property, including research data, proprietary formulas, and clinical trial results. A breach could lead to financial losses, legal repercussions, reputational damage, and public health concerns. What’s more, pharmaceutical and biomedical life sciences data breaches cost $4.82 million on average — and rank third highest across industries (behind only healthcare and finance).
Read our guide on the latest trends in the life sciences industry.
Understanding the top challenges of content management in life sciences
Let’s review the top content management challenges in life sciences:
| Challenge | Description | Solution |
|---|---|---|
| Data volume and storage scalability | Life sciences generate vast amounts of data, which require scalable storage to accommodate the volume | Implement cloud-based solutions and scalable infrastructure to handle large datasets efficiently |
| Unstructured data | R&D data often comes in unstructured formats, making it challenging to organize, search, and analyze effectively | Use artificial intelligence and content management tools to classify and extract valuable insights from unstructured data |
| Data quality and accuracy | Scientific endeavor requires accurate and reliable information for sound R&D and public safety | Employ validation processes and automation to minimize human errors and guarantee data integrity |
| Interoperability and data silos | Lack of standardization and compatibility between different data formats, plus information scattered across various sources and databases, leads to silos | Adopt standardized formats, leverage data integration tools, and centralize your content management systems to break down silos and promote collaboration |
| Data security | Life sciences data is highly sensitive and must be protected from cyber threats and unauthorized access | Adopt robust cybersecurity measures, including encryption, access controls, and regular audits |
| Regulatory compliance | The sector is heavily regulated to ensure sensitive data remains secure, as well as the safety and efficacy of therapies and devices | Follow industry-specific regulations and standards, while also maintaining detailed audit trails and documentation |
Learn how to eliminate silos across your scientific content workflows. Download our ebook about Intelligent Content Management for Life Sciences.
How to improve content management in the pharmaceutical and biotech industry
If you’re looking for ways to revamp your content management systems in life sciences, consider these measures.
1. Centralize your content in the cloud
With a centralized platform to store, share, and access all your content, your team knows where to find files quickly. By leveraging enterprise cloud storage solutions, researchers, scientists, and stakeholders access critical information from anywhere in the world, fostering seamless collaboration across geographically dispersed teams and research centers.
The cloud also provides a scalable storage infrastructure to accommodate the increasing volume of research and clinical data. When it comes to cloud migration, McKinsey reports that Fortune 500 pharma and medtech companies stand to gain, on average, about $25 billion to $30 billion in improved 2030 EBITDA run rates from business innovation. By transitioning your clinical trial management from paper-based and in-person to digital and remote, you’re able to cut down costs and accelerate time to market.
2. Leverage enterprise-grade security and compliance
Encryption, access controls, and regular security audits are foundational to a comprehensive security strategy in life sciences.
- With a centralized, secure vault for your content, you establish sharing roles, link expiration, ethical walls, and more
- With the use of machine learning models and artificial intelligence tools for native data loss protection (DLP) and cyber threat detection, you proactively mitigate cyber risks
- With cloud backup and disaster recovery capabilities, you ensure research findings and intellectual property remain safe and accessible
Equally important is the adherence to stringent compliance standards, such as GxP for pharmaceutical companies. If your enterprise content management system offers GxP dashboards and GAMP5-validation templates designed specifically for cloud solutions, you simplify compliance while saving on validation costs.
3. Automate your R&D content workflows
Digital workflow automation reduces repetitive and manual tasks that are prone to human errors. By accelerating the process of exchanging, reviewing, and approving clinical documents, you speed up your R&D timelines.
Take the example of biopharma companies that often partner with contract research organizations (CROs) for clinical trials and pharmacokinetics studies, generating extensive documentation. With automated content management, you enable a seamless exchange of data between pharmaceutical firms and CROs, ensuring that information flows smoothly while maintaining data integrity and security.
By automating data transfer, patient record verification, validation, and reporting processes, the R&D lifecycle becomes more efficient, minimizing errors and accelerating the development timeline.
Secure life sciences data management with Box
With Box for life sciences, you streamline collaboration, innovate faster, and stay compliant. Intelligent Content Management from Box provides a secure source of truth for all your R&D data.
We help you overcome common life sciences content management challenges by centralizing your data on an all-inclusive platform for creating, storing, sharing, and collaborating. This way, you eliminate inefficient content silos between multiple data repositories and share information faster with CROs and other external teams.
We simplify compliance, too. Our GxP Validation enables life sciences companies to validate Box so they work with, manage, and distribute all of their non-regulated and regulated content — including clinical and lab data. With enterprise-grade security, you don’t have to worry about breaches. We leverage granular permissions, zero trust security, AES 256-bit encryption, and much more to make sure your most sensitive data is safe.
By removing the hurdles of content management in life sciences, you’re able to focus on scientific innovation. Contact us, and let’s explore all you can do with Box-powered clinical collaboration.
Box for life sciences FAQs
What is a life sciences document management platform, and why do pharma and biotech companies need one?
Managing regulated and unregulated content across clinical trials, quality systems, and manufacturing is one of the most complex challenges in life sciences — and a purpose-built document management platform is how leading organizations solve it. Without one, your teams spend critical time hunting for files across disconnected systems, manual handoffs slow down studies and approvals, and audit readiness becomes a reactive scramble. Box provides an Intelligent Content Management platform purpose-built for the regulatory, collaboration, and operational demands of pharmaceutical, biotech, and medical device organizations. When your content is centralized and governed from day one, you reduce risk, accelerate time-to-market, and walk into every inspection with confidence.
How does Box support GxP-validated workflows and 21 CFR Part 11 compliance?
Box is a GxP-validated platform that supports the full lifecycle of regulated content — including audit trails, version control, retention and disposition policies, and chain-of-custody documentation required for regulatory submissions and inspections.
Box Sign provides 21 CFR Part 11–style e-signatures and signature logs, so you can execute consent forms, protocols, and quality documents compliantly without paper-based workarounds. Box Shield adds zero-trust security controls, automated data classification, and threat detection to keep sensitive content protected at every stage. Together, these capabilities give your quality and regulatory teams a defensible, auditable record that supports FDA and EMA scrutiny.
What is clinical trial document management, and how does it improve study operations?
Clinical trial document management is the practice of organizing, controlling, and maintaining all documents generated during a clinical study — including the Trial Master File, investigator site files, protocols, and eConsent forms — in a way that meets regulatory standards and supports efficient collaboration. When your study documents live in fragmented systems, version conflicts, delayed approvals, and missed audit deadlines become the norm.
Box centralizes eTMF creation, investigator site file management, protocol submissions, and SAS dataset handling in a single platform with automated folder structures, metadata tagging, and version control. Your clinical operations teams spend less time managing files and more time advancing studies.
How does Box help pharma and biotech companies collaborate with CROs and CDMOs?
Sponsor–CRO collaboration is one of the most document-intensive, time-sensitive challenges in clinical operations, and fragmented tools make it worse. Box gives you secure, controlled portals that let CROs, CDMOs, investigators, and other external partners access exactly the content they need — without compromising governance or exposing sensitive data.
Companies that use Box for CRO onboarding report more than 50% cost savings per new partner onboarded, driven by faster setup, fewer support tickets, and eliminated manual file-sharing workarounds. With Box Automate handling workflow handoffs and Box Shield enforcing permissions, your external collaboration stays compliant from first file share to final closeout.
What does virtual inspection readiness mean, and how can a content platform help?
Virtual inspection readiness means your organization can respond to an FDA, EMA, or notified body inspection — conducted remotely — with immediate, organized access to all required documentation, audit trails, and quality records. Regulators increasingly conduct inspections without setting foot on-site, so your ability to surface the right document at the right moment is a direct measure of your compliance posture. Box supports virtual inspection readiness by centralizing SOPs, batch records, audit logs, and quality documents in a single, permission-controlled repository with complete version history. When an inspector asks for a document, your team retrieves it in seconds — not hours — and every version, approval, and access event is logged and ready to present.
How does Box address HIPAA compliance and data security for life sciences organizations?
Protecting patient data and proprietary research is non-negotiable in life sciences, and Box is built to meet that standard. Box supports HIPAA compliance requirements and a zero-trust security model with granular permissions, automated content classification, and data-loss prevention through Box Shield. Audit trails capture every access, edit, and share event, giving your security and privacy teams a complete record for compliance reporting and incident response. Whether you're handling real-world evidence, patient consent data, or clinical trial results, Box keeps sensitive content secure across your entire ecosystem of internal teams and external partners.
How do pharmaceutical companies streamline the promotional content review and MLR approval process?
Medical, legal, and regulatory review is one of the most time-consuming bottlenecks in pharmaceutical commercialization, and manual routing through email or disconnected tools only makes it slower. Box Automate routes promotional materials through the right reviewers in the right sequence, captures approvals, and maintains a complete audit trail for 2253 filing. Box Hubs gives your field teams and medical science liaisons a curated, always-current portal for approved promotional assets and scientific exchange materials. The result is faster time-to-market for compliant content and fewer regulatory observations tied to unapproved materials in the field.
How does Box help life sciences companies manage mergers, acquisitions, and post-merger content integration?
M&A activity in life sciences generates enormous volumes of content that must be migrated, reorganized, and governed quickly — often under tight regulatory and business timelines. Box Shuttle migrates content from legacy systems, file servers, and SharePoint environments while preserving permissions, metadata, and version history, so nothing is lost in transition. Companies using Box for post-merger integration report 50% time savings on M&A activity compared to manual migration approaches. With Box Governance applying retention and disposition policies automatically, your newly combined organization starts with a clean, compliant content foundation from day one.
What is AI for life sciences, and how can regulated organizations use it safely?
AI for life sciences means using artificial intelligence to extract insights from unstructured scientific and operational content — accelerating document review, surfacing relevant data across studies, and automating repetitive knowledge work. The challenge is doing this safely: in a regulated environment, AI must operate within strict access controls and compliance frameworks, not around them.
Box AI works within Box permissions and governance controls, so AI-generated summaries, metadata extractions, and multi-document queries are based only on content a user is authorized to see. With Box AI + Hubs, your teams can ask questions across curated SOPs, study materials, quality documentation, and regulatory content — and with Box AI Studio, you can build custom AI agents that automate multi-step review, extraction, and routing workflows entirely within your governed content environment, giving you the speed of AI without the compliance risk of shadow tools or uncontrolled data exposure.
How does Box help life sciences companies consolidate tools and reduce technology costs?
Most life sciences organizations run a sprawling mix of point solutions for e-signatures, file sharing, workflow automation, and content storage — each with its own contract, support burden, and integration overhead.
Box consolidates these capabilities into a single Intelligent Content Management platform, giving you document management, Box Sign for e-signatures, Box Automate for workflow automation, Box Shield for security, and Box AI for intelligence in one place. Customers have reported more than $200K in annual savings from tool consolidation alone, in addition to reduced IT support costs and faster user onboarding. Signant Health and Jazz Pharma are among the life sciences organizations that have used Box to retire legacy systems and simplify their content technology stack.
How do biotech and pharma companies manage GMP compliance and manufacturing quality documentation?
Digital transformation in pharmaceutical and biotech manufacturing means replacing paper-based batch records, manual supplier qualification processes, and siloed quality systems with governed, auditable digital workflows. Box centralizes digitized batch records, GMP audit documentation, and supplier qualification portals in a single platform with automated retention policies and complete audit trails.
Box Automate routes review and approval workflows for quality documents, reducing manual handoffs between sites and partners and cutting the risk of version errors. Your manufacturing and quality operations teams get the traceability and control they need to pass GMP audits and support continuous improvement.
How do I get started with Box for my life sciences or biotech organization?
Getting started with Box means connecting your most pressing content challenge — whether that's eTMF management, CRO collaboration, virtual inspection readiness, or tool consolidation — to a platform that's already validated, integrated, and trusted by organizations like Biogen, Jazz Pharma, and Signant Health.
Box offers a GxP-validated environment, pre-built workflow templates for clinical and quality use cases, and a library of 1,500+ integrations with systems like Microsoft 365, Salesforce, ComplianceQuest, and LIMS. Box Shuttle handles migration from your existing file servers or legacy platforms, preserving metadata and permissions so your transition is low-risk. Request a demo at box.com/industries/life-sciences-biotech to connect with the Box life sciences team and map your specific use cases to a deployment plan that fits your regulatory and operational requirements.
Power seamless R&D collaboration with Box
**While we maintain our steadfast commitment to offering products and services with best-in-class privacy, security, and compliance, the information provided in this blogpost is not intended to constitute legal advice. We strongly encourage prospective and current customers to perform their own due diligence when assessing compliance with applicable laws.
